Annual CFF
$39.22 M
-$13.68 M-25.87%
December 31, 2022
Summary
- As of February 10, 2025, SELB annual cash flow from financing activities is $39.22 million, with the most recent change of -$13.68 million (-25.87%) on December 31, 2022.
- During the last 3 years, SELB annual CFF has fallen by -$65.83 million (-62.67%).
Performance
SELB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$24.79 M
-$22.20 M-858.58%
September 30, 2023
Summary
- As of February 10, 2025, SELB quarterly cash flow from financing activities is -$24.79 million, with the most recent change of -$22.20 million (-858.58%) on September 30, 2023.
- Over the past year, SELB quarterly CFF has dropped by -$25.40 million (-4150.49%).
Performance
SELB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
-$27.23 M
-$25.40 M-1391.84%
September 30, 2023
Summary
- As of February 10, 2025, SELB TTM cash flow from financing activities is -$27.23 million, with the most recent change of -$25.40 million (-1391.84%) on September 30, 2023.
- Over the past year, SELB TTM CFF has dropped by -$87.60 million (-145.10%).
Performance
SELB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SELB Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.9% | -4150.5% | -145.1% |
| 3 y3 years | -62.7% | -218.3% | -132.7% |
| 5 y5 years | -40.6% | -9821.2% | -125.9% |
SELB Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | at low | -167.2% | at low | -144.5% | at low |
| 5 y | 5-year | -62.7% | -63.2% | -136.2% | at low | -125.9% | at low |
| alltime | all time | -62.7% | -98.2% | -136.2% | at low | -125.9% | at low |
Selecta Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$24.79 M(+858.6%) | -$27.23 M(+1391.8%) |
| Jun 2023 | - | -$2.59 M(-1835.6%) | -$1.82 M(-104.8%) |
| Mar 2023 | - | $149.00 K(>+9900.0%) | $37.64 M(-4.0%) |
| Dec 2022 | $39.22 M(-25.9%) | $0.00(-100.0%) | $39.22 M(-35.0%) |
| Sep 2022 | - | $612.00 K(-98.3%) | $60.37 M(-1.4%) |
| Jun 2022 | - | $36.88 M(+2034.0%) | $61.21 M(+83.7%) |
| Mar 2022 | - | $1.73 M(-91.8%) | $33.32 M(-37.0%) |
| Dec 2021 | $52.90 M(+266.6%) | $21.16 M(+1359.0%) | $52.90 M(+67.7%) |
| Sep 2021 | - | $1.45 M(-83.9%) | $31.55 M(-38.2%) |
| Jun 2021 | - | $8.98 M(-57.8%) | $51.05 M(+24.2%) |
| Mar 2021 | - | $21.31 M(<-9900.0%) | $41.11 M(+184.9%) |
| Dec 2020 | $14.43 M(-86.3%) | -$190.00 K(-100.9%) | $14.43 M(-82.6%) |
| Sep 2020 | - | $20.95 M(-2288.9%) | $83.16 M(+23.7%) |
| Jun 2020 | - | -$957.00 K(-82.2%) | $67.23 M(-1.9%) |
| Mar 2020 | - | -$5.37 M(-107.8%) | $68.56 M(-34.7%) |
| Dec 2019 | $105.04 M | $68.53 M(+1263.0%) | $105.04 M(+187.1%) |
| Sep 2019 | - | $5.03 M(+1251.6%) | $36.59 M(+15.0%) |
| Jun 2019 | - | $372.00 K(-98.8%) | $31.81 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $31.11 M(>+9900.0%) | $31.75 M(+4455.7%) |
| Dec 2018 | $697.00 K(-98.9%) | $80.00 K(-68.6%) | $697.00 K(-87.7%) |
| Sep 2018 | - | $255.00 K(-18.0%) | $5.66 M(-55.6%) |
| Jun 2018 | - | $311.00 K(+509.8%) | $12.73 M(-80.8%) |
| Mar 2018 | - | $51.00 K(-99.0%) | $66.37 M(+0.5%) |
| Dec 2017 | $66.02 M(-2.4%) | $5.04 M(-31.3%) | $66.02 M(+3.5%) |
| Sep 2017 | - | $7.33 M(-86.4%) | $63.78 M(+8.5%) |
| Jun 2017 | - | $53.95 M(<-9900.0%) | $58.80 M(-14.8%) |
| Mar 2017 | - | -$292.00 K(-110.5%) | $69.04 M(+2.0%) |
| Dec 2016 | $67.66 M(+54.1%) | $2.79 M(+18.4%) | $67.66 M(-4.1%) |
| Sep 2016 | - | $2.36 M(-96.3%) | $70.55 M(-29.6%) |
| Jun 2016 | - | $64.19 M(-3927.4%) | $100.18 M(+136.1%) |
| Mar 2016 | - | -$1.68 M(-129.5%) | $42.44 M(-3.3%) |
| Dec 2015 | $43.91 M(+77.2%) | $5.69 M(-82.2%) | $43.91 M(+14.9%) |
| Sep 2015 | - | $31.98 M(+396.5%) | $38.22 M(+513.0%) |
| Jun 2015 | - | $6.44 M(-3212.1%) | $6.24 M(-3112.1%) |
| Mar 2015 | - | -$207.00 K | -$207.00 K |
| Dec 2014 | $24.77 M | - | - |
FAQ
- What is Selecta Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Selecta Biosciences?
- What is Selecta Biosciences annual CFF year-on-year change?
- What is Selecta Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Selecta Biosciences?
- What is Selecta Biosciences quarterly CFF year-on-year change?
- What is Selecta Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Selecta Biosciences?
- What is Selecta Biosciences TTM CFF year-on-year change?
What is Selecta Biosciences annual cash flow from financing activities?
The current annual CFF of SELB is $39.22 M
What is the all time high annual CFF for Selecta Biosciences?
Selecta Biosciences all-time high annual cash flow from financing activities is $105.04 M
What is Selecta Biosciences annual CFF year-on-year change?
Over the past year, SELB annual cash flow from financing activities has changed by -$13.68 M (-25.87%)
What is Selecta Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of SELB is -$24.79 M
What is the all time high quarterly CFF for Selecta Biosciences?
Selecta Biosciences all-time high quarterly cash flow from financing activities is $68.53 M
What is Selecta Biosciences quarterly CFF year-on-year change?
Over the past year, SELB quarterly cash flow from financing activities has changed by -$25.40 M (-4150.49%)
What is Selecta Biosciences TTM cash flow from financing activities?
The current TTM CFF of SELB is -$27.23 M
What is the all time high TTM CFF for Selecta Biosciences?
Selecta Biosciences all-time high TTM cash flow from financing activities is $105.04 M
What is Selecta Biosciences TTM CFF year-on-year change?
Over the past year, SELB TTM cash flow from financing activities has changed by -$87.60 M (-145.10%)